Methotrexate therapy of oral corticosteroid-dependent asthmatics reduces serum immunoglobulins: Correlation with clinical response to therapy

Clinical and Experimental Allergy

Volumn 35, Issue 5, 2005, Pages 579-584

  Corrigan, Chris J ^a,c   Shiner, R J ^b   Shakur, B H ^b   Ind, P W ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^c GUY S HOSPITAL   (United Kingdom)

Author keywords

Asthma; Corticosteroid; Immunoglobulin; Lymphocyte; Methotrexate

Indexed keywords

BECLOMETASONE; CORTICOSTEROID; IMMUNOGLOBULIN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IPRATROPIUM BROMIDE; METHOTREXATE; PREDNISOLONE; XANTHINE;

ADULT; ARTICLE; ASTHMA; CLINICAL ARTICLE; CLINICAL TRIAL; CORRELATION ANALYSIS; CORTICOSTEROID THERAPY; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG WITHDRAWAL; FOLLOW UP; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; LEUKOCYTE; LEUKOCYTE DIFFERENTIAL COUNT; LYMPHOCYTOPENIA; PANCYTOPENIA; PRIORITY JOURNAL; T LYMPHOCYTE;

ADMINISTRATION, ORAL; ADULT; ASTHMA; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FORCED EXPIRATORY VOLUME; HUMANS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOGLOBULINS; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, INTRAMUSCULAR; LEUKOCYTE COUNT; METHOTREXATE; PREDNISOLONE; TREATMENT OUTCOME;

EID: 20044387677     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2005.02253.x     Document Type: Article

References (22)

1. Marin MG. Low-dose methotrexate spares steroid usage in steroid-dependent chronic asthmatic patients: a meta-analysis. Chest 1997; 112:29-33.
2. Aaron SD, Dales RE, Pham B. Management of steroid-dependent asthma with methotrexate: a meta-analysis of randomised clinical trials. Respir Med 1998; 92:1059-65.
3. Kremer JM, Galivan J, Streckfuss A, Kamen B. Methotrexate metabolism analysis in blood and liver of rheumatoid arthritis patients: association with hepatic folate deficiency and formation of polyglutamates. Arthritis Rheum 1986; 329: 832-5.
4. Corrigan CJ, Shiner R, Shakur BH, Ind PW. Methotrexate therapy in asthma increases T cell susceptibility to corticosteroid inhibition. Clin Exp Allergy 2003; 33:1090-6.
5. Milgrom H, Fick RB, Su JQ et al. Treatment of allergic asthma with monoclonal anti-IgE antibody. N Engl J Med 1999; 341: 1966-73.
6. Bernstein IL, Bernstein DI, Dubb JW, Faiferman I, Wallin B. A placebo-controlled multicenter study in the treatment of corticosteroid- dependent chronic severe asthma. J Allergy Clin Immunol 1996; 98:317-24.
7. Charous BL, Halpern EF, Steven GC. Hydroxychloroquine improves airflow and lowers circulating IgE levels in subjects with moderate symptomatic asthma. J Allergy Clin Immunol 1998; 102:198-203.
8. Nakano Y, Morita S, Kawamoto A et al. Elevated complement C3a in plasma from patients with severe acute asthma. J Allergy Clin Immunol 2003; 112:525-30.
9. Gerard NP, Gerard C. Complement in allergy and asthma. Curr Opin Immunol 2002; 14:705-8.
10. Shiner RJ, Nunn AJ, Chung KF, Geddes DM. Randomised, double-blind, placebo-controlled trial of methotrexate in steroid-dependent asthma. Lancet 1990; 336:137-40.
11. Posey WC, Nelson HS, Branch B et al. The effects of acute corticosteroid therapy for asthma on serum immunoglobulin levels. J Allergy Clin Immunol 1978; 62:340-5.
12. Grayson J, Pooley NJ, Koski IR et al. Immunoglobulin production induced in vitro by glucocorticoid hormones. J Clin Invest 1981; 68:1539-46.
13. Zieg G, Lack G, Harbeck EJ et al. In vivo effects of glucocorticoids on IgE production. J Allergy Clin Immunol 1994; 94:222-6.
14. Inokuma S, Kono H, Nakayama H, Yamazaki J. Immunoglobulin and lymphocyte decrease concurrent with adverse reactions induced by methotrexate for RA. Ann Rheum Dis 2000; 59:495-6.
15. Rackham OJ, Sills JA, Davidson JE. Immunoglobulin levels in methotrexate treated paediatric rheumatology patients. Arch Dis Child 2002; 87:147-8.
16. Fairbanks LD, Ruckemann K, Qiu Y et al. Methotrexate inhibits the first committed step of purine biosynthesis in mitogen-stimulated human T-lymphocytes: a metabolic basis for efficacy in rheumatoid arthritis? Biochem J 1999; 342:143-52.
17. Chan ESL, Cronstein BN. Molecular action of methotrexate in inflammatory diseases. Arthritis Res 2002; 4:266-73.
18. Mirabel M, Herrera C, Cordero OJ et al. Expression of A2B adenosine receptors in human lymphocytes: their role in T cell activation. J Cell Sci 1999; 112:491-502.
19. Glynnbarnhart AM, Erzurum SC, Leff JA et al. Effect of low-dose methotrexate on the disposition of glucocorticoids and theophylline. J Allergy Clin Immunol 1991; 88:180-6.
20. Olsen NJ, Teal GP, Brooks RH. IgM-rheumatoid factor and responses to second-line drugs in rheumatoid arthritis. Agents Actions 1991; 34:169-71.
21. Morice AM, Lai WK. Fatal varicella-zoster infection in a severe steroid-dependent asthmatic patient receiving methotrexate. Thorax 1995; 50:1221-2.
22. Kuitert LM, Harrison AC. Pneumocystis carinii pneumonia as a complication of methotrexate treatment of asthma. Thorax 1991; 46:936-7.